+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viral Transport Medium Market - Global Outlook & Forecast 2022-2027

  • PDF Icon


  • 274 Pages
  • July 2022
  • Region: Global
  • Arizton
  • ID: 5639216
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global viral transport medium market is expected to grow at a CAGR of 3.51% during 2022-2027

Viral transport mediums are the medical kits, swabs, and tubes used to collect, preserve, and transport viral specimens for research and diagnostic tests, which exist in several formulations, consisting of a buffered salt solution, a complex source of protein and amino acids, and anti-microbial agents. It preserves virus and is either used for amplification by nucleic acid amplification testing (NAAT) technology or viral culture. It allows research collection, preservation, and transportation of viral specimens, including conventional cell culture methods, molecular biology techniques, and diagnostic tests. The importance of viral transport medium was known globally when a new H1N1 influenza virus was identified, causing the world's first flu pandemic in more than 40 years. Since then, it has been used majorly by hospitals, labs, and academic/research institutes for transporting viral samples across the research and clinical value chain. During the transport, the virus, if present, in the sample specimen should remain intact until the testing is completed.

More recently, the sudden onset of the COVID-19 pandemic significantly changed the demand for transport medium products and related kits. With the fast spread of the COVID-19 virus, many countries prioritized diagnostic testing for quick diagnosis of the virus. This fuelled the exponential increase in demand for VTM kits for sample collection from suspected COVID-19 patients. Owing to the surge in demand for diagnostic tests and sample collection from people, many vendors increased their production.
They continuously tried to deliver many viral transport media kits to meet the exponential demand for COVID-19 diagnostic tests. In March 2020, increased demand for covid-19 testing led to a global shortage of nasopharyngeal swabs and viral transport medium (VTM) test kits that significantly impacted large-scale testing efforts.


Suddenly increased SARS-COV-2 infection rate drive substantial demand for VTM kits. It resulted in increased manufacturing and manufacturing capacity of the vendors. Most of the leading and emerging companies took part in fulfilling VTM supply across the healthcare system in the world. In 2020, Thermo Fisher Scientific, one of the leading suppliers of viral transport kits, invested around $40 million in Lenexa and Kansas manufacturing facilities to scale up the production of the kits.

The pandemic increased the manufacturing of VTM kits globally and gave emerging market players new opportunities. Several new entries and new products were launched in the same period. Most of the global market players looked for a maximum supply of these kits; on the other side, newcomers entered with new products.
  • In June 2020, India bases IIT Guwahati developed a new VTM product. The product name is SPLID VTM Kit is a unique and world-class affordable solution which are the first-stop source helped in the collection of oral and nasal swabs specimen.
  • In 2021, the leading manufacturing company of viral transport media, Vircell, launched a new VTM kit solution. This product is validated for collecting and preserving viruses such as SARS-COV-2 & influenza A virus.
  • The UK-based company EKF diagnostic launched a new molecular transport media product for influenza and Covid-19 virus collection. It is one of the unique products that novel transport molecular media used for the dual purpose such as covid-19 and influenza sampling and enabled safe sample handling and testing with one sample swab.


Viral transport medium kits are constantly in demand due to the increasing prevalence of infectious diseases. Viral infections are one of the major burdens seen in the pandemic period. The rising prevalence of viral infectious diseases enabled the growth of viral transport media kits. Some of the viral infectious diseases are Covid-19, influenza virus, enterovirus D68, herpes, varicella, RSV, etc. In diagnosing the diseases mentioned above, collection of samples, preservation, and transportation is required, whereas VTM kits are the most prominently used solutions by the practitioners. According to the Plos One article 2021, based on studies documented from 2007 to 2020, the overall prevalence of respiratory syncytial virus was around 11%, and adenovirus accounted for 13%. Influenza viral infection accounted high burden worldwide, which required diagnosis and test.

Non-polio enterovirus causes around 10-15 million infection cases annually & on the other side, 10,000 hospitalizations each year in the US. On the other side, herpes is one of the severe viral infectious conditions that demand laboratory testing for diagnosis and cure. It is categorized into the herpes simplex virus type 1 and herpes simplex virus type 2. It is a sexually transmitted infection that is present lifelong. Around 3.7 billion people under 50 suffer from HSV-1 and 491 million from HSV-2 under the age of 15-49-year-old.

The rising covid-19 test across the world accounted high consumption rate of VTM test kits. More than millions of tests were done daily from June 2020 to Jan 2022, which significantly changed the market and delivered a major turning point for market.

On the other side, increasing the diagnosis rate for viral infectious diseases constantly drives the market growth. The increasing diagnosis rate of viral diseases requires laboratory testing of clinical specimens to identify the virus, viral antigens, and antibodies. Last form two decades major revolution was addressed in the virus diagnostic laboratories. Also, the rapid increase in the aging population, rise in the number of people undergoing various voluntary surgeries, and other factors have accelerated the requirement for various diagnostic tests that involve VTM kits. With the rising prevalence of various acute and chronic diseases worldwide, the number of surgeries performed to treat such diseases is also increasing rapidly.

A surge in Mass Testing for COVID-19 & Influenza

The demand for viral transport has increased exponentially during the COVID-19 pandemic. With academic/research institutes intensifying their experiments for developing vaccines and mass testing to stop the spread of COVID-19 globally, vendors have increased their manufacturing capacities and produced billions of VTM kits. Companies focus on innovation and developing kits containing double-ended flocked swabs, vials, antibiotics, and other items that inhibit microbial contamination. In addition, with the continuous increase of seasonal flu cases, manufacturers are also manufacturing viral transport for influenza tests, owing to influenza-related morbidity and mortality in many countries.


Product Insights

The global viral transport medium market is segmented into viral transport media, universal transport media, & molecular transport media. In 2021, viral transport media accounted for a revenue share of 46% in the global viral transport medium market and dominated other segments. The universal transport media segment accounted for 34%, and the molecular transport media segment accounted for 20% market share in 2021.

Usage Insights

The global viral transport kit market is segmented into diagnosis and pre-clinical testing. The rising diagnosis rate of covid-19 cases drives significant market growth by diagnosing severe SARS-COV-2 infection. In 2021, the diagnosis segment accounted for a revenue share of 67.44% in the global viral transport media market and showed dominance over the pre-clinical testing segment.

Indication Insights

Global Viral Transport Medium Market by indication is segmented into influenza & covid-19, herpes simplex virus, varicella-zoster virus, respiratory syncytial virus (RSV), and other adenoviruses, rhinoviruses, enteroviruses, parainfluenza viruses, metapneumoviruses, etc. Influenza is one of the common viral infections globally. In the global Viral Transport Medium Market, the influenza& covid-19 indication segment accounted for 73.09% market share in 2021. The higher infection rate of Covid-19 across the world dominated the market with a higher market share.

End-user Insights

Global Viral Transport Medium Market by end-user segmented into the labs, hospitals & clinics, and another end-user segment. In 2021, the lab's segment accounted for a revenue share of 40.30% in the global viral transport media market and dominated to other two segments. An increasing number of microbiology labs, research labs, biotech labs, and pharmaceutical and biotech company/ organizational labs drive viral transport kits' adoption and contribute to the market growth with dominance over other segments.

Segmentation by Products

  • Viral Transport Media
  • Universal Transport Media
  • Molecular Transport Media

Segmentation by Usage

  • Diagnosis
  • Pre-Clinical Testing

Segmentation by Indication

  • Influenza & Covid
  • Herpes Simplex Virus
  • Respiratory Syncytial Virus
  • Varicella Zoster Virus
  • Others

Segmentation by End-User

  • Diagnostic Labs
  • Hospitals & Clinics
  • Others


The market is segmented into North America, Europe, APAC, Latin America, and the Middle East & Africa region. In North America, a high number of laboratory tests were registered during the pandemic, fueling the market growth. On the other side, the presence of biopharma companies, a high number of labs, well-developed healthcare services, and research studies on viral infection drives significant market growth in the region and accounted 33.18% higher market share. Apart from the Covid-19 pandemic burden, other viral infections such as influenza, herpes, varicella, respiratory syncytial virus, and other viral infectious diseases demand the diagnosis where VTM kits play a vital role in the collection, preservation, and transportation of specimens. The rising prevalence of viral infection across the world delivers high demand for VTM kits. Influenza viral infections continue to increase in African, North America, and Asia Pacific regions.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • UK
  • France
  • Italy
  • Germany
  • Spain
  • APAC
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa


The global viral transport medium market is highly competitive in nature due to the presence of domestic, regional, and international market players. Also, the geographical presence of key market players and their broad distribution channels increases market competitiveness through their major supply, import, and export strategies. The outbreak of the COVID-19 pandemic significantly increased demand for VTM kits, driving high export and import of VTM kits from different countries through major market players. Vendors are increasing efforts to manufacture VTM products as per regulatory bodies' requirements. For instance, Hardy Diagnostics, an FDA-licensed manufacturer of medical devices for microbiological testing, launched the Universal Transport Medium, which is suitable for collection, maintenance, and long-term freeze storage of clinical specimens. Apart from hospital and retail pharmacies, vendors also offer huge volumes of orders from online pharmacies. Hence, they collaborate with e-commerce companies to increase their sales and revenue options.

Key Vendors

  • BD (Beckton Dickinson)
  • Hardy Diagnostics
  • HiMedia Laboratories
  • Laboratory Corporation of America
  • Puritan Medical Products
  • Thermo Fisher Scientific
  • Vircell

Other Prominent Vendors

  • AB Medical
  • AccuGene USA
  • Apical Scientific
  • Azooka Labs
  • Biomed Diagnostics
  • bioBoaVista
  • Biogenex Laboratories
  • Biologix Group
  • Biocomma
  • Charm Sciences
  • Creative Life Sciences Co. Ltd
  • Citotest Labware Manufacturing
  • CPT Medical
  • Copan Diagnostic Inc.
  • Diasorin Molecular
  • EKF Diagnostic
  • Ensol Biosciences
  • Gemini Bioproducts
  • General Biologics
  • Gentueri
  • Genesis Lifetech Marketing
  • Han Chang Medic
  • Hebei Chaoran Medical Instruments
  • KSL Diagnostics
  • Lucence Health
  • LaunchWorks
  • Liofilchem
  • Medical Wire & Equipment
  • Miraclean Technology (Mantacc)
  • MetaDesign Solutions
  • Manila HealthTek
  • MatTek
  • Nodford International
  • Starplex Scientific
  • Sansure Biotech
  • Titan Biotech
  • Vegas Biotech
  • Zybio



Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Increasing Demand for Vtm Due to Surge in Covid-19 Infection
8.2 Launch of New Products and Entry of New Market Players
9 Market Growth Enablers
9.1 Increasing Prevalence of Viral Infectious Diseases
9.2 Surge in Covid-19 Infections
9.3 Increase in Diagnosis of Viral Infectious Diseases
10 Market Restraints
10.1 Vtm Specimens Pose Higher Biohazard During Transportation Than Other Solutions
10.2 False-Negative Results in Borderline Cases
10.3 Lack of Access to Diagnosis Services in Lmics
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Products
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Viral Transport Media
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Market by Geography
12.4 Universal Transport Media
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Market by Geography
12.5 Molecular Transport Media
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.5.3 Market by Geography
13 Usage
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Diagnosis
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market by Geography
13.4 Pre-Clinical Testing
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market by Geography
14 Indication
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Influenza & Covid-19
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market by Geography
14.4 Herpes Simplex Virus
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market by Geography
14.5 Respiratory Syncytial Virus (Rsv)
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Market by Geography
14.6 Varicella-Zoster
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Market by Geography
14.7 Others
14.7.1 Market Overview
14.7.2 Market Size & Forecast
14.7.3 Market by Geography
15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Labs
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Market by Geography
15.4 Hospitals & Clinics
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Market by Geography
15.5 Others
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Market by Geography
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Product
17.3.1 Market Size & Forecast
17.4 Usage
17.4.1 Market Size & Forecast
17.5 Indication
17.5.1 Market Size & Forecast
17.6 End-User
17.6.1 Market Size & Forecast
17.7 Key Countries
17.7.1 Us: Market Size & Forecast
17.7.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Product
18.3.1 Market Size & Forecast
18.4 Usage
18.4.1 Market Size & Forecast
18.5 Indication
18.5.1 Market Size & Forecast
18.6 End-User
18.6.1 Market Size & Forecast
18.7 Key Countries
18.7.1 Uk: Market Size & Forecast
18.7.2 France: Market Size & Forecast
18.7.3 Italy: Market Size & Forecast
18.7.4 Germany: Market Size & Forecast
18.7.5 Spain: Market Size & Forecast
19 Apac
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Product
19.3.1 Market Size & Forecast
19.4 Usage
19.4.1 Market Size & Forecast
19.5 Indication
19.5.1 Market Size & Forecast
19.6 End-User
19.6.1 Market Size & Forecast
19.7 Key Countries
19.7.1 China: Market Size & Forecast
19.7.2 Japan: Market Size & Forecast
19.7.3 India: Market Size & Forecast
19.7.4 Australia: Market Size & Forecast
19.7.5 South Korea: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Product
20.3.1 Market Size & Forecast
20.4 Usage
20.4.1 Market Size & Forecast
20.5 Indication
20.5.1 Market Size & Forecast
20.6 End-User
20.6.1 Market Size & Forecast
20.7 Key Countries
20.7.1 Brazil: Market Size & Forecast
20.7.2 Mexico: Market Size & Forecast
20.7.3 Argentina: Market Size & Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Product
21.3.1 Market Size & Forecast
21.4 Usage
21.4.1 Market Size & Forecast
21.5 Indication
21.5.1 Market Size & Forecast
21.6 Usage
21.6.1 Market Size & Forecast
21.7 End-User
21.7.1 Market Size & Forecast
21.8 Key Countries
21.8.1 Turkey: Market Size & Forecast
21.8.2 Saudi Arabia: Market Size & Forecast
21.8.3 South Africa: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
23 Key Company Profiles
23.1 Bd (Becton Dickinson)
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Hardy Diagnostics
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Himedia Laboratories
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Laboratory Corporation of America
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Puritan Medical Products
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Thermo Fisher Scientific
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.7 Vircell
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
24 Other Prominent Vendors
24.1 Ab Medical
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 Accugene Usa
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Apical Scientific
24.3.1 Business Overview
24.3.2 Product Offering
24.4 Azooka Labs
24.4.1 Business Overview
24.4.2 Product Offering
24.5 Biomed Diagnostics
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Bioboavista
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Biogenex Laboratories
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Biologix Group
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 Biocomma
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Charm Sciences
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Creative Life Sciences Co. Ltd.
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Citotest Labware Manufacturing
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Cpt Medical
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Copan Diagnostic Inc.
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Diasorin Molecular
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 Ekf Diagnostics Holdings plc
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 Ensol Biosciences
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 Gemini Bioproducts
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 General Biologics
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Gentueri
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 Genesis Lifetech Marketing
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 Han Chang Medic
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 Hebei Chaoran Medical Instruments
24.23.1 Business Overview
24.23.2 Product Offering
24.24 Ksl Diagnostics
24.24.1 Business Overview
24.24.2 Product Offering
24.25 Lucence Health
24.25.1 Business Overview
24.25.2 Product Offerings
24.26 Launchworks
24.26.1 Business Overview
24.26.2 Product Offering
24.27 Liofilchem
24.27.1 Business Overview
24.27.2 Product Offering
24.28 Medical Wire & Equipment (Mwe)
24.28.1 Business Overview
24.28.2 Product Offerings
24.29 Miraclean Technology
24.29.1 Business Overview
24.29.2 Product Offerings
24.30 Metadesign Solutions
24.30.1 Business Overview
24.30.2 Product Offerings
24.31 Manila Healthtek
24.31.1 Business Overview
24.31.2 Product Offering
24.32 Mattek
24.32.1 Business Overview
24.32.2 Product Offering
24.33 Nodford International
24.33.1 Business Overview
24.33.2 Product Offering
24.34 Starplex Scientific
24.34.1 Business Overview
24.34.2 Product Offerings
24.35 Sansure Biotech
24.35.1 Business Overview
24.35.2 Product Offerings
24.36 Titan Biotech
24.36.1 Business Overview
24.36.2 Product Offerings
24.37 Vegas Biotech
24.37.1 Business Overview
24.37.2 Product Offering
24.38 Zybio
24.38.1 Business Overview
24.38.2 Product Offering
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Market by Geography
26.2 Market by Product
26.3 Market by Usage
26.4 Market by Indication
26.5 Market by End-User
26.6 Product: Market by Geography
26.6.1 Viral Transport Media: Market by Geography
26.6.2 Universal Transport Media: Market by Geography
26.6.3 Molecular Transport Media: Market by Geography
26.7 Usage: Market by Geography
26.7.1 Diagnosis: Market by Geography
26.7.2 Pre-Clinical Testing: Market by Geography
26.8 Indication: Market by Geography
26.8.1 Influenza & Covid-19: Market by Geography
26.8.2 Herpes: Market by Geography
26.8.3 Respiratory Syncytial Virus: Market by Geography
26.8.4 Varicella Zoster Virus: Market by Geography
26.8.5 Other Indications: Market by Geography
26.9 End-User: Market by Geography
26.9.1 Labs: Market by Geography
26.9.2 Hospitals & Clinics: Market by Geography
26.9.3 Other Indication: Market by Geography
27 Appendix
27.1 Abbreviations

Companies Mentioned

  • BD (Beckton Dickinson)
  • Hardy Diagnostics
  • HiMedia Laboratories
  • Laboratory Corporation of America
  • Puritan Medical Products
  • Thermo Fisher Scientific
  • Vircell
  • AB Medical
  • AccuGene USA
  • Apical Scientific
  • Azooka Labs
  • Biomed Diagnostics
  • bioBoaVista
  • Biogenex Laboratories
  • Biologix Group
  • Biocomma
  • Charm Sciences
  • Creative Life Sciences Co. Ltd
  • Citotest Labware Manufacturing
  • CPT Medical
  • Copan Diagnostic Inc.
  • Diasorin Molecular
  • EKF Diagnostic
  • Ensol Biosciences
  • Gemini Bioproducts
  • General Biologics
  • Gentueri
  • Genesis Lifetech Marketing
  • Han Chang Medic
  • Hebei Chaoran Medical Instruments
  • KSL Diagnostics
  • Lucence Health
  • LaunchWorks
  • Liofilchem
  • Medical Wire & Equipment
  • Miraclean Technology (Mantacc)
  • MetaDesign Solutions
  • Manila HealthTek
  • MatTek
  • Nodford International
  • Starplex Scientific
  • Sansure Biotech
  • Titan Biotech
  • Vegas Biotech
  • Zybio


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.